Patient-Centered Cancer Prevention In Chinese Americans
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 10/20/2018 |
| Start Date: | August 15, 2018 |
| End Date: | November 2020 |
| Contact: | Janet Pan |
| Email: | Janet.Pan@nyumc.org |
| Phone: | 212 263 0483 |
This study will assess the efficacy, adoption, and impact of an integrated intervention to
improve adherence to recommended stomach cancer prevention guidelines (H. pylori
test-and-treat) for at-risk Chinese Americans in NYC. The integrated multifaceted
theory-based intervention involves: 1) a health systems-level intervention using electronic
health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies; and 2) a
community-engaged culturally and linguistically adapted CHW-led patient navigation program we
are currently pilot testing for feasibility and acceptability. Using a 2-arm randomized
controlled trial (RCT) design, > 144 Chinese American patients across NYC safety net hospital
endoscopy clinics and primary health centers will participate.
improve adherence to recommended stomach cancer prevention guidelines (H. pylori
test-and-treat) for at-risk Chinese Americans in NYC. The integrated multifaceted
theory-based intervention involves: 1) a health systems-level intervention using electronic
health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies; and 2) a
community-engaged culturally and linguistically adapted CHW-led patient navigation program we
are currently pilot testing for feasibility and acceptability. Using a 2-arm randomized
controlled trial (RCT) design, > 144 Chinese American patients across NYC safety net hospital
endoscopy clinics and primary health centers will participate.
Inclusion Criteria:
- self identifies as Chinese American
- is an outpatient aged 21 years and older (adult)
- plans to continue to live in the region during the next 12 months;
- is willing to be randomized to either treatment or control groups
- has a confirmed diagnosis of H. pylori infection by at least one of the following
methods: C-urea breath test, histology, rapid urease test or bacterial culture, fecal
stool antigen test or other clinically approved H. pylori infection diagnostic test.
Exclusion Criteria:
- advanced chronic disease that would not allow the patient to complete follow-up or
attend visits;
- allergy to any of the study drugs;
- pregnancy or currently breastfeeding
- taking antibiotics or bismuth salts within 2 weeks before the study.
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Simona Kwon, PhD, MPH
Phone: 212-263-0483
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
